Page last updated: 2024-09-03

myelopeptide 1 and Chronic Illness

myelopeptide 1 has been researched along with Chronic Illness in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Khabarov, AS; Kolesnikov, AP; Kozlov, VA	1
Borisova, AM; Glazko, AV; Petrov, RV; Simonova, AV; Stepanenko, RN	1

Other Studies

2 other study(ies) available for myelopeptide 1 and Chronic Illness

Article	Year
[Diagnosis and differentiated treatment of secondary immunodeficiencies]. Terapevticheskii arkhiv, 2001, Volume: 73, Issue:4 Topics: Acute Disease; Adjuvants, Immunologic; Antibody Formation; Biomarkers; Bronchitis; Chronic Disease; Cytokines; Drug Combinations; Fluorescent Antibody Technique, Indirect; Homeostasis; Humans; Immunity, Cellular; Immunocompromised Host; Immunoglobulins; Immunologic Deficiency Syndromes; Immunologic Factors; Infections; Inflammation; Interferon Type I; Oligopeptides; Phagocyte Bactericidal Dysfunction; Phagocytes; Pneumonia; Recurrence; Rosette Formation; Shock, Septic; Suppuration; T-Lymphocytes; Time Factors; Virus Diseases	2001
[Efficacy of myelopid in immunodeficiency states]. Terapevticheskii arkhiv, 1990, Volume: 62, Issue:12 Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Agammaglobulinemia; B-Lymphocytes; Bronchitis; Chronic Disease; Female; Humans; Immune Tolerance; Leukocyte Count; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Pneumonia; Remission Induction; T-Lymphocytes	1990

Article

Year

[Diagnosis and differentiated treatment of secondary immunodeficiencies].

Terapevticheskii arkhiv, 2001, Volume: 73, Issue:4

Topics: Acute Disease; Adjuvants, Immunologic; Antibody Formation; Biomarkers; Bronchitis; Chronic Disease; Cytokines; Drug Combinations; Fluorescent Antibody Technique, Indirect; Homeostasis; Humans; Immunity, Cellular; Immunocompromised Host; Immunoglobulins; Immunologic Deficiency Syndromes; Immunologic Factors; Infections; Inflammation; Interferon Type I; Oligopeptides; Phagocyte Bactericidal Dysfunction; Phagocytes; Pneumonia; Recurrence; Rosette Formation; Shock, Septic; Suppuration; T-Lymphocytes; Time Factors; Virus Diseases

2001

[Efficacy of myelopid in immunodeficiency states].

Terapevticheskii arkhiv, 1990, Volume: 62, Issue:12

Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; Agammaglobulinemia; B-Lymphocytes; Bronchitis; Chronic Disease; Female; Humans; Immune Tolerance; Leukocyte Count; Middle Aged; Multiple Sclerosis; Oligopeptides; Peptides; Pneumonia; Remission Induction; T-Lymphocytes

1990